Leinco Technologies

Anti-Human CD62E (E-Selectin) - PE

Product Code:
 
LEI-C676
Product Group:
 
Primary Antibodies
Host Type:
 
Mouse
Antibody Isotype:
 
IgG1
Antibody Clonality:
 
Monoclonal
Antibody Clone:
 
1.2B6
Regulatory Status:
 
RUO
Target Species:
 
Human
Application:
 
Flow Cytometry
Shipping:
 
2-8°C
Storage:
 
Store at 2-8°C protected from light. DO NOT FREEZE. For long term storage aliquot conjugate into working volumes and store at 2-8°C for up to a year.
 

No additional charges, what you see is what you pay! *

CodeSizePrice
LEI-C676-100tests100 tests£606.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: US.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • References
  • Related Products
  • Show All

Further Information

Conjugate/Tag/Label:
R-phycoerythrin (PE)
Format:
This conjugate is formulated in phosphate buffered saline (PBS), 1 mg/ml BSA and 10 mM sodium azide as a preservative.
Formulation:
This conjugate is formulated in phosphate buffered saline (PBS), 1 mg/ml BSA and 10 mM sodium azide as a preservative.
Immunogen:
TNF-Activated Human Umbilical Vein Endothelial Cells
Long Description:
CD62E, also known as E-Selectin, is a type I membrane glycoprotein that belongs to the selectin family of surface molecules which is activated by cytokines and mediates the binding of leukocytes. Like other selectins, it plays an important part in inflammation. During inflammation, E-selectin plays an important part in recruiting leukocytes to the site of injury.
NCBI Gene:
6401
Target:
CD62E

References

1. Leukocyte Typing Workshop VI (1996) Oxford University Press 2. Leukocyte Typing Workshop V (1995) Oxford University Press 3. Bevilacqua, M. P. et al. (1993) J. Clin. Invest. 91:379 4. Groves, R. W. et al. (1991) Br. J. Dermatol. 124:117 5. Wellicome, S. M. et al. (1990) J. Immunol. 144:2558